ABEO
Abeona Therapeutics Inc
4.90$
-0.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -327.0% | – | – | – | -346.3% | – | -4,696.0% | – | -331.2% | -227.1% | -153.7% | -299.5% | |
| – | 25.5% | – | – | – | 16.2% | – | 192.0% | – | 20.1% | 10.0% | 7.3% | 14.4% | |
| – | 53.6% | – | – | – | 40.9% | – | 707.5% | – | -2.6% | 33.9% | 29.6% | 34.8% | |
| – | 35.9% | – | – | – | -80.2% | – | 3,913.3% | – | -10.9% | -16.7% | -79.2% | -110.0% | |
| – | 1.3% | – | – | – | 12.7% | – | 725.3% | – | 21.3% | 10.7% | 4.2% | 19.9% | |
| – | 408.3% | – | – | – | 394.7% | – | 38,972.0% | – | 176.3% | 56.9% | 137.8% | -134.9% | |
| – | -6.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0% | – | 0.0% | – | 0.0% | -25.5% | -29.3% | -21.8% | |
| – | 264.4% | – | – | – | 111.1% | – | 2,623.8% | – | 66.7% | -25.5% | -29.3% | 12.6% | |
| – | 345.6% | – | – | – | 159.6% | – | 36,899.8% | – | -88.3% | -195.7% | -45.2% | -421.8% | |
| – | -328.3% | – | – | – | -359.0% | – | -5,421.3% | – | -352.5% | -237.8% | -158.0% | -319.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.